BlueSkeye AI, a United Kingdom-based company, was founded in April 2019 as a spin-out from the University of Nottingham. The startup emphasizes ethical artificial intelligence, specifically targeting the analysis of medically relevant expressive behavior with the slogan: "Ethical AI for the analysis of Medically Relevant Expressive Behaviour".
Operating at the intersection of AI and Health Care, BlueSkeye AI has quickly established itself as a promising entity within its industry. The company successfully closed a €3.80M Seed Round on 21 October 2022, securing investments from notable entities such as Praetura Ventures, Foresight Group, XTX Ventures, WDH Investments, and its academic origin, the University of Nottingham.
With a strong foundational backing and a clear mission to leverage AI for societal benefit, BlueSkeye AI presents a viable opportunity for investors interested in technology-driven health solutions.